TSE:KPTKP Tissue Stock Price, Forecast & News

KP Tissue's stock was trading at C$11.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, KPT shares have increased by 5.4% and is now trading at C$11.68.
View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for KP Tissue.

KP Tissue is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020.
View our earnings forecast for KP Tissue.

KP Tissue Inc (TSE:KPT) issued its quarterly earnings data on Friday, May, 8th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.02. The firm earned $375.15 million during the quarter, compared to the consensus estimate of $345.70 million.
View KP Tissue's earnings history.

KP Tissue declared a quarterly dividend on Wednesday, May 20th. Stockholders of record on Friday, July 3rd will be paid a dividend of 0.18 per share on Wednesday, July 15th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 6.16%. The ex-dividend date of this dividend is Thursday, July 2nd.
View KP Tissue's dividend history.

4 analysts have issued 12-month price targets for KP Tissue's stock. Their forecasts range from C$11.00 to C$13.00. On average, they anticipate KP Tissue's share price to reach C$12.10 in the next twelve months. This suggests a possible upside of 3.6% from the stock's current price.
View analysts' price targets for KP Tissue.

News articles about KPT stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. KP Tissue earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future.
View the latest news about KP Tissue.

Some companies that are related to KP Tissue include McBride (MCB), Churchill China (CHH), Swallowfield (SWL), Creightons (CRL), Byotrol (BYOT), Provexis (PXS), CCA Industries (CAW), Scott's Liquid Gold (SLGD) and Unibail Rodamco (UL).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other KP Tissue investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Open Text (OTEX), Rogers Communications (RCI) and Valeant Pharmaceuticals Intl (VRX).

KP Tissue trades on the Toronto Stock Exchange (TSX) under the ticker symbol "KPT."

Shares of KPT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

One share of KPT stock can currently be purchased for approximately C$11.68.

KP Tissue has a market capitalization of C$112.84 million.

The official website for KP Tissue is kptissueinc.com.

KP Tissue's mailing address is 1900 Minnesota Crt Suite 200, MISSISSAUGA, ON L5N 5R5, Canada. The company can be reached via phone at +1-905-8126900.